Biologic choice matters in PsA prevention

Nature Reviews Rheumatology, Published online: 24 March 2023; doi:10.1038/s41584-023-00955-zIn a large cohort of patients with psoriasis, treatment with biologic DMARDs targeting the IL-23 pathway was associated with a reduced risk of developing inflammatory arthritis as compared with anti-TNF treatment.
Source: Nature Reviews Rheumatology - Category: Rheumatology Authors: Source Type: research